Aclarion Financials
| ACONW Stock | USD 0.03 0 8.20% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.32 | 0.4045 |
|
|
Investors should never underestimate Aclarion's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Aclarion's cash flow, debt, and profitability to make informed and accurate decisions about investing in Aclarion.
Net Income |
|
Aclarion | Select Account or Indicator |
Understanding current and past Aclarion Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aclarion's financial statements are interrelated, with each one affecting the others. For example, an increase in Aclarion's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Aclarion's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aclarion. Check Aclarion's Beneish M Score to see the likelihood of Aclarion's management manipulating its earnings.
Aclarion Stock Summary
Aclarion competes with Aclarion, and Heartbeam Warrant. Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy in the United States. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California. Aclarion Inc operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 655187110 |
| Location | California; U.S.A |
| Business Address | 8181 Arista Place, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.aclarion.com |
| Phone | 833 275 2266 |
| Currency | USD - US Dollar |
Aclarion Key Financial Ratios
| Return On Equity | -7.14 | ||||
| Operating Margin | (103.51) % | ||||
| Revenue | 75.4 K | ||||
| EBITDA | (4.14 M) | ||||
| Net Income | (4.91 M) |
Aclarion Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aclarion's current stock value. Our valuation model uses many indicators to compare Aclarion value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aclarion competition to find correlations between indicators driving Aclarion's intrinsic value. More Info.Aclarion is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At this time, Aclarion's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Aclarion by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Aclarion Systematic Risk
Aclarion's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aclarion volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Aclarion correlated with the market. If Beta is less than 0 Aclarion generally moves in the opposite direction as compared to the market. If Aclarion Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aclarion is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aclarion is generally in the same direction as the market. If Beta > 1 Aclarion moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Aclarion is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Aclarion has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Aclarion's financials are consistent with your investment objective using the following steps:- Review Aclarion's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Aclarion's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Aclarion's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Aclarion's stock is overvalued or undervalued.
Aclarion Thematic Clasifications
Aclarion is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Healthcare | View |
Today, most investors in Aclarion Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aclarion's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aclarion growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Aclarion November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aclarion help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aclarion. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aclarion based on widely used predictive technical indicators. In general, we focus on analyzing Aclarion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aclarion's daily price indicators and compare them against related drivers.
| Downside Deviation | 9.61 | |||
| Information Ratio | 0.0635 | |||
| Maximum Drawdown | 58.58 | |||
| Value At Risk | (15.28) | |||
| Potential Upside | 27.09 |
Additional Tools for Aclarion Stock Analysis
When running Aclarion's price analysis, check to measure Aclarion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclarion is operating at the current time. Most of Aclarion's value examination focuses on studying past and present price action to predict the probability of Aclarion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclarion's price. Additionally, you may evaluate how the addition of Aclarion to your portfolios can decrease your overall portfolio volatility.